DAPK1 and malignant colon neoplasm: Study has shown that pyrimidine-based DAPK1/colony stimulating factor 1 receptor (CSF1R) dual inhibitor can significantly inhibit the proliferation of various tumor cell lines, including colon cancer cell line29.